Social Context of Adherence in an Open-Label 1 % Tenofovir Gel Trial: Gender Dynamics and Disclosure in KwaZulu-Natal, South Africa

AIDS and Behavior

Volumn 20, Issue 11, 2016, Pages 2682-2691

  MacQueen, Kathleen M ^a   Dlamini, Sarah ^b   Perry, Brian ^a   Okumu, Eunice ^a   Sortijas, Steve ^a   Singh, Chitra ^b   Pillay, Diantha ^b   Majors, Alesha ^a   Jerome, Sonja ^a   Watson, Sharon ^a   Karim, Salim Abdool ^b   Karim, Quarraisha Abdool ^b   Mansoor, Leila E ^b  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Adherence; Disclosure; Gender dynamics; Microbicide; Tenofovir gel

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; TENOFOVIR;

ADOLESCENT; ADULT; FEMALE; GEL; GENDER IDENTITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RELATION; INTERPERSONAL COMMUNICATION; MALE; MEDICATION COMPLIANCE; PRE-EXPOSURE PROPHYLAXIS; PSYCHOLOGY; SELF DISCLOSURE; SEX DIFFERENCE; SOUTH AFRICA;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; FEMALE; GELS; GENDER IDENTITY; HIV INFECTIONS; HUMANS; INTERPERSONAL RELATIONS; MALE; MEDICATION ADHERENCE; NEGOTIATING; PRE-EXPOSURE PROPHYLAXIS; SELF DISCLOSURE; SEX FACTORS; SOUTH AFRICA; TENOFOVIR;

EID: 84960127816     PISSN: 10907165     EISSN: 15733254     Source Type: Journal    
DOI: 10.1007/s10461-016-1339-4     Document Type: Article

References (13)

1. Domanska CA, Teitelman AM. Factors that affect acceptance of HIV microbicides among women. Collegian. 2012;19(1):23–32.
2. Woodsong C, MacQueen K, Amico KR, Friedland B, Gafos M, Mansoor L, et al. Microbicide clinical trial adherence: insights for introduction. J Int AIDS Soc. 2013;16:18505. doi:10.7448/IAS.16.1.18505.
3. Montgomery ET, Straten A, Stadler J, Hartmann M, Magazi B, Mathebula F, et al. Male partner influence on women’s HIV prevention trial participation and use of pre-exposure prophylaxis: the importance of “understanding”. AIDS Behav. 2014;17((3Suppl 2)):19146. doi:10.1007/s10461-014-0950-5.
4. Karim QA, Karim SSA, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74.
5. Mansoor LE, Abdool Karim Q, Mngadi KT, Dlamini S, Montague C, Nkomonde N, et al. Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial. Trials. 2014;15:496. doi:10.1186/1745-6215-15-496.
6. Mngadi KT, Maarschalk S, Grobler AC, Mansoor LE, Frohlich JA, Madlala B, et al. Disclosure of microbicide gel use to sexual partners: influence on adherence in the CAPRISA 004 trial. AIDS Behav. 2014;18(5):849–54. doi:10.1007/s10461-014-0696-0.
7. Succop SM, MacQueen KM, van Loggerenberg F, Majola N, Karim QA, Karim SS. Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial. AIDS Care. 2014;26(12):1521–5. doi:10.1080/09540121.2014.938014.
8. Guest G, MacQueen KM, Namey EE. Applied thematic analysis. Thousand Oaks: Sage; 2011.
9. Boeije H. A purposeful approach to the constant comparative method in the analysis of qualitative interviews. Qual Quant. 2002;36:391–409.
10. Lanham M, Wilcher R, Montgomery ET, Pool R, Schuler S, Lenzi R, et al. Engaging male partners in women’s microbicide use: evidence from clinical trials and implications for future research and microbicide introduction. J Int AIDS Soc. 2014;17(3 Suppl 2):19159. doi:10.7448/IAS.17.3.19159.
11. Perry B, Oluoch L, Agot K, Taylor J, Onyango J, Ouma L, et al. Widow cleansing and inheritance among the Luo in Kenya: the need for additional women-centred HIV prevention options. J Int AIDS Soc. 2014;17:19010. doi:10.7448/IAS.17.1.19010.
12. Headley J, Lemons A, Corneli A, Agot K, Ahmed K, Wang M, et al. The sexual risk context among the FEM-PrEP study population in Bondo, Kenya and Pretoria, South Africa. PLoS One. 2014;9(9):e106410. doi:10.1371/journal.pone.0106410.
13. van der Straten A, Stadler J, Luecke E, Laborde N, Hartmann M, Montgomery ET, et al. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa. J Int AIDS Soc. 2014;17(3 Suppl 2):19146. doi:10.7448/IAS.17.3.19146.